MAPK8 and atherosclerosis: The authors demonstrated an independent association between low AZGP1 levels and atherosclerosis, and provided experimental evidence indicating that AZGP1 exerts anti-inflammatory effects via the β3-adrenoceptor and JNK/AP-1 signaling in macrophages and possibly in other cells surrounding atherosclerotic plaques.